Innoviva (INVA) Capital Expenditures (2010 - 2026)
Innoviva posted quarterly Capital Expenditures of $492000.0 for Q1 2026, down 56.11% on a QoQ basis from $1.1 million in Q3 2025.
Innoviva (INVA) has 14 years of Capital Expenditures data on file, last reported at $492000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures changed N/A year-over-year to $492000.0; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 597.41% YoY), and the FY2025 full-year result was $1.1 million, up 318.89% from the prior year.
- Capital Expenditures for Q1 2026 stood at $492000.0, down from $1.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.1 million in Q3 2025 and bottomed at $9000.0 in Q1 2022.
- The 5-year median for Capital Expenditures is $146500.0 (2022), against an average of $278875.0.
- The widest annual swing landed in 2023, when Capital Expenditures soared 687.88%; it then increased 3.85% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $33000.0 in 2022, then jumped by 687.88% to $260000.0 in 2023, then climbed by 3.85% to $270000.0 in 2024, then jumped by 315.19% to $1.1 million in 2025, then sank by 56.11% to $492000.0 in 2026.
- The last three Capital Expenditures figures came in at $492000.0 (Q1 2026), $1.1 million (Q3 2025), and $270000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 492,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 492,000.00 |
| Mar 31, 2026 | 492,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2024 | 270,000.00 |
| Sep 30, 2024 | 270,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Sep 30, 2016 | 242,000.00 |
| Sep 30, 2016 | 242,000.00 |
| Jun 30, 2016 | 8,000.00 |
| Jun 30, 2016 | 8,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | 133,000.00 |
| Dec 31, 2014 | 133,000.00 |
| Jun 30, 2014 | -1.06 Mn |
| Jun 30, 2014 | -1.06 Mn |
| Mar 31, 2014 | 1.62 Mn |
| Mar 31, 2014 | 1.62 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Sep 30, 2013 | 236,000.00 |
| Sep 30, 2013 | 236,000.00 |
| Jun 30, 2013 | 691,000.00 |
| Jun 30, 2013 | 691,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Dec 31, 2012 | 261,000.00 |
| Dec 31, 2012 | 261,000.00 |
| Sep 30, 2012 | 567,000.00 |
| Sep 30, 2012 | 567,000.00 |
| Jun 30, 2012 | 659,000.00 |
| Jun 30, 2012 | 659,000.00 |
| Mar 31, 2012 | 1.10 Mn |
| Mar 31, 2012 | 1.10 Mn |
| Dec 31, 2011 | 905,000.00 |
| Dec 31, 2011 | 905,000.00 |
| Sep 30, 2011 | -40,000.00 |
| Sep 30, 2011 | -40,000.00 |
| Jun 30, 2011 | 1.38 Mn |
| Jun 30, 2011 | 1.38 Mn |
| Mar 31, 2011 | 1.38 Mn |
| Mar 31, 2011 | 1.38 Mn |
| Dec 31, 2010 | 575,000.00 |
| Dec 31, 2010 | 575,000.00 |
| Sep 30, 2010 | 153,000.00 |
| Sep 30, 2010 | 153,000.00 |